Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen and N-acetylcysteine for Vasospasm in aSAH
NCT00585559Phase 3Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2007
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetaminophen and acetylcysteine in aneurysmal subarachnoid hemorrhage (SAH) (5 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Number of Patients With Vasospasm Based on Magnetic Resonance Angiography at 8 days, Number of Patients With Vasospasm Based on Computed Tomographic Angiography at 8 days and 4 more. Started Apr 2007; status: terminated.
02
Drugs
acetaminophenacetylcysteine
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00585559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585559.